June 27th! You're invited! Zynlonta: CD-19-direct ADC for 3L DLBCLSocial Media CoordinatorJun 20, 20230 min readJune 27th - ADC event.pdfDownload PDF • 723KB
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Comments